Development of LOX-1 Antibody Modified Immuno-liposomes as Drug Carriers to Macrophages in Atherosclerotic Lesions.

Togami, K; Zhan, X; Ishizawa, K; Miyakoshi, K; Miyao, A; Quan, P; Chono, S

Development of LOX-1 Antibody Modified Immuno-liposomes as Drug Carriers to Macrophages in Atherosclerotic Lesions.

Togami, K; Zhan, X; Ishizawa, K; Miyakoshi, K; Miyao, A; Quan, P; Chono, S.

Affiliation

Togami K; Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Hokkaido University of Science, 7-Jo 15-4-1 Maeda, Teine, Sapporo, Hokkaido 006-8585, Japan.
Chono S; Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Hokkaido University of Science, 7-Jo 15-4-1 Maeda, Teine, Sapporo, Hokkaido 006-8585, Japan.

Pharmazie ; 78(8): 113-116, 2023 08 01.

Article in En | MEDLINE | ID: mdl-37592420

Subject(s)

Atherosclerosis; Liposomes; Animals; Mice; Drug Carriers; Antibodies; Macrophages; Apolipoproteins E; Atherosclerosis/drug therapy; Scavenger Receptors, Class E

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Atherosclerosis / Liposomes Limits: Animals Language: En Journal: Pharmazie Year: 2023 Document type: Article

Fulltext

XML

PubMed Links

Search on Google